Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes

被引:6
|
作者
Ewers, Bettina [1 ]
Bruun, Jens Meldgaard [2 ,3 ]
Vilsboll, Tina [1 ,4 ]
机构
[1] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[2] Steno Diabet Ctr Aarhus, Aarhus, Denmark
[3] Univ Aarhus, Dept Clin Med, Aarhus, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源
BMJ OPEN | 2019年 / 9卷 / 11期
关键词
MANAGEMENT; LITERACY; NUMERACY; ADULTS; PREVENTION; CONSENSUS; THERAPY; SKILLS;
D O I
10.1136/bmjopen-2019-032893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Recommendations on energy intake are key in body weight management to improve glycaemic control in people with type 2 diabetes (T2D). International clinical guidelines recommend a variety of eating patterns to promote energy restriction as the primary dietetic approach to body weight control in managing T2D. In addition, individualised guidance on self-monitoring carbohydrate intake to optimise meal timing and food choices (eg, basic carbohydrate counting (BCC)) is recommended to achieve glycaemic control. However, the evidence for this approach in T2D is limited. The objective of this study was to compare the effect of an educational programme in BCC as add-on to the usual dietary care on glycaemic control in people with T2D. Methods and analyses The study is designed as a randomised, controlled trial with a parallel-group design. The study duration is 12 months with data collection at baseline, and after 6 and 12 months. We plan to include 226 adults with T2D. Participants will be randomised to one of two interventions: (1) BCC as add-on to usual dietary care or (2) usual dietary care. The primary outcome is changes in glycated haemoglobin A1c or mean amplitude of glycaemic excursions from baseline and after 6-month intervention between and within study groups. Further outcome measures include changes in time in range, body weight and composition, lipid profile, blood pressure, mathematical literacy skills, carbohydrate estimation accuracy, dietary intake, diet-related quality of life, perceived competencies in diet and diabetes and perceptions of an autonomy supportive dietician-led climate, physical activity and urinary biomarkers.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Random Blood Glucose, but Not HbA1c, Was Associated with Mortality in COVID-19 Patients with Type 2 Diabetes Mellitus-A Retrospective Study
    Kandinata, Stefanus Gunawan
    Soelistijo, Soebagijo Adi
    Pranoto, Agung
    Triyono, Erwin Astha
    PATHOPHYSIOLOGY, 2023, 30 (02) : 136 - 143
  • [22] Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: An analysis of the ORBIT study
    Shu, Hua
    Lu, Juming
    Zhang, Puhong
    Zhu, Dongshan
    Li, Xian
    Ji, Jiachao
    Zhao, Fang
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (04)
  • [23] HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study
    Ohde, Sachiko
    Deshpande, Gautam A.
    Yokomichi, Hiroshi
    Takahashi, Osamu
    Fukui, Tsuguya
    Yamagata, Zentaro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 135 : 166 - 171
  • [24] Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Shin, Juyoung
    Chang, Jin-Sun
    Kim, Hun-Sung
    Ko, Sun-Hee
    Cha, Bong-Yun
    Son, Ho-Young
    Yoon, Kun-Ho
    Cho, Jae-Hyoung
    DIABETES & METABOLISM JOURNAL, 2012, 36 (05) : 364 - 370
  • [25] Association of HbA1c Variability with Vibrating Perception Threshold in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
    Ding, Jingcheng
    Shi, Qian
    Dong, Ling
    Su, Hong
    Du, Yijun
    Pan, Tianrong
    Zhong, Xing
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 193 - 202
  • [26] HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
    Penno, Giuseppe
    Solini, Anna
    Bonora, Enzo
    Fondelli, Cecilia
    Orsi, Emanuela
    Zerbini, Gianpaolo
    Morano, Susanna
    Cavalot, Franco
    Lamacchia, Olga
    Laviola, Luigi
    Nicolucci, Antonio
    Pugliese, Giuseppe
    DIABETES CARE, 2013, 36 (08) : 2301 - 2310
  • [27] The Effect of a cognitive behavioral program based on an interactive application on serum glucose levels and HbA1C of family members of patients with type 2 diabetes: a study protocol for a randomized clinical trial
    Bahramnezhad, Fatemeh
    Jackson, Alun C.
    Ghorbani, Banafsheh
    Kahnouei, Mahmoud Shiri
    Sharifi, Farshad
    Negarandeh, Reza
    Salamat, Elaheh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 23 (2) : 2385 - 2393
  • [28] Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial
    Matthias Blüher
    Julio Rosenstock
    Josef Hoefler
    Raymond Manuel
    Anita M. Hennige
    Diabetologia, 2024, 67 : 470 - 482
  • [29] Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
    Hiroshi Nomoto
    Chiho Oba-Yamamoto
    Yuka Takahashi
    Jun Takeuchi
    So Nagai
    Hiroki Yokoyama
    Shinji Taneda
    Yoshio Kurihara
    Shin Aoki
    Hiraku Kameda
    Kyu Yong Cho
    Akinobu Nakamura
    Tatsuya Atsumi
    Hideaki Miyoshi
    Diabetes Therapy, 2021, 12 : 955 - 964
  • [30] Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
    Nomoto, Hiroshi
    Oba-Yamamoto, Chiho
    Takahashi, Yuka
    Takeuchi, Jun
    Nagai, So
    Yokoyama, Hiroki
    Taneda, Shinji
    Kurihara, Yoshio
    Aoki, Shin
    Kameda, Hiraku
    Cho, Kyu Yong
    Nakamura, Akinobu
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES THERAPY, 2021, 12 (03) : 955 - 964